Amphotericin B is considered the “gold standard” of antifungal agents. Technically, its mode of action works against most fungal infections. Why, then, isn’t it prescribed for most fungal infections?

검증된 단계별 안내

Step 1: Understand the mode of action of Amphotericin B. It binds to ergosterol, a key component of fungal cell membranes, creating pores that increase membrane permeability and cause cell death.

Step 2: Recognize that while Amphotericin B is effective against a broad range of fungi, its interaction with ergosterol can also affect cholesterol in human cell membranes, leading to toxicity.

Step 3: Identify the main side effects associated with Amphotericin B, such as nephrotoxicity (kidney damage), infusion-related reactions, and electrolyte imbalances, which limit its use.

Step 4: Consider that due to these toxic effects, Amphotericin B is often reserved for severe or life-threatening fungal infections where benefits outweigh risks.

Step 5: Note that for less severe fungal infections, safer antifungal agents with fewer side effects are preferred, which explains why Amphotericin B is not prescribed for most fungal infections despite its effectiveness.

비슷한 문제에 대한 검증된 영상 답변:

이 영상 해법은 위 문제에 도움이 된다고 튜터들이 추천한 것입니다.

영상 길이:

도움이 되었나요?

주요 개념

질문에 올바르게 답하기 위해 반드시 이해해야 하는 핵심 개념들은 다음과 같습니다.

Mode of Action of Amphotericin B

Amphotericin B binds to ergosterol, a key component of fungal cell membranes, creating pores that cause ion leakage and cell death. This mechanism makes it effective against a broad range of fungi by disrupting membrane integrity.

Toxicity and Side Effects

Despite its effectiveness, Amphotericin B has significant toxicity, especially nephrotoxicity (kidney damage), infusion-related reactions, and electrolyte imbalances. These adverse effects limit its use to severe or resistant fungal infections.

Alternative Antifungal Agents

Other antifungal drugs, such as azoles and echinocandins, have fewer side effects and are easier to administer. These alternatives are preferred for less severe infections, reserving Amphotericin B for cases where other treatments fail or are inappropriate.